Adiuvo Investments S.A. (ADV.WA)
PLN 0.98
(-0.2%)
PLN 0.98
(-0.2%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 983 Thousand PLN | -2698.89% |
| 2022 | 180 Thousand PLN | -72.93% |
| 2021 | 665 Thousand PLN | 2.15% |
| 2020 | 651 Thousand PLN | -42.54% |
| 2019 | 1.13 Million PLN | -17.84% |
| 2018 | 1.37 Million PLN | -41.86% |
| 2017 | 2.37 Million PLN | 80.93% |
| 2016 | 1.31 Million PLN | -5.82% |
| 2015 | 1.39 Million PLN | 150.51% |
| 2014 | -2.75 Million PLN | -17125.0% |
| 2013 | -16 Thousand PLN | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -65 Thousand PLN | 94.29% |
| 2024 Q1 | -1.13 Million PLN | -49.93% |
| 2023 Q3 | 47 Thousand PLN | 102.47% |
| 2023 Q4 | -759 Thousand PLN | -1714.89% |
| 2023 FY | -4.67 Million PLN | -2698.89% |
| 2023 Q1 | 49 Thousand PLN | 132.89% |
| 2023 Q2 | -1.9 Million PLN | -3985.71% |
| 2022 Q2 | -42 Thousand PLN | -140.78% |
| 2022 Q4 | -149 Thousand PLN | -260.22% |
| 2022 Q3 | 93 Thousand PLN | 321.43% |
| 2022 Q1 | 103 Thousand PLN | -72.31% |
| 2022 FY | 180 Thousand PLN | -72.93% |
| 2021 FY | 665 Thousand PLN | 2.15% |
| 2021 Q3 | 116 Thousand PLN | 90.16% |
| 2021 Q4 | 372 Thousand PLN | 220.69% |
| 2021 Q1 | 116 Thousand PLN | -73.7% |
| 2021 Q2 | 61 Thousand PLN | -47.41% |
| 2020 Q2 | 31 Thousand PLN | -69.61% |
| 2020 Q3 | 77 Thousand PLN | 148.39% |
| 2020 FY | 651 Thousand PLN | -42.54% |
| 2020 Q1 | 102 Thousand PLN | -76.44% |
| 2020 Q4 | 441 Thousand PLN | 472.73% |
| 2019 Q1 | 184 Thousand PLN | 194.36% |
| 2019 FY | 1.13 Million PLN | -17.84% |
| 2019 Q4 | 433 Thousand PLN | 82.7% |
| 2019 Q3 | 237 Thousand PLN | -15.05% |
| 2019 Q2 | 279 Thousand PLN | 51.63% |
| 2018 Q4 | -195 Thousand PLN | -127.31% |
| 2018 FY | 1.37 Million PLN | -41.86% |
| 2018 Q2 | 97 Thousand PLN | -71.13% |
| 2018 Q1 | 336 Thousand PLN | -78.57% |
| 2018 Q3 | 714 Thousand PLN | 636.08% |
| 2017 Q4 | 1.56 Million PLN | 437.93% |
| 2017 Q1 | 1.91 Million PLN | 137.3% |
| 2017 FY | 2.37 Million PLN | 80.93% |
| 2017 Q3 | -464 Thousand PLN | 28.28% |
| 2017 Q2 | -647 Thousand PLN | -133.79% |
| 2016 Q2 | -227 Thousand PLN | -128.7% |
| 2016 Q4 | 807 Thousand PLN | 1445.0% |
| 2016 FY | 1.31 Million PLN | -5.82% |
| 2016 Q3 | -60 Thousand PLN | 73.57% |
| 2016 Q1 | 791 Thousand PLN | -17.43% |
| 2015 Q4 | 958 Thousand PLN | 189.43% |
| 2015 Q3 | 331 Thousand PLN | 47.77% |
| 2015 FY | 1.39 Million PLN | 150.51% |
| 2015 Q2 | 224 Thousand PLN | 258.87% |
| 2015 Q1 | -141 Thousand PLN | 89.89% |
| 2014 Q1 | -22 Thousand PLN | 0.0% |
| 2014 Q2 | -589 Thousand PLN | -2577.27% |
| 2014 Q3 | -56 Thousand PLN | 90.49% |
| 2014 Q4 | -1.39 Million PLN | -2389.29% |
| 2014 FY | -2.75 Million PLN | -17125.0% |
| 2013 FY | -16 Thousand PLN | 0.0% |
| 2013 Q4 | - PLN | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Genomtec S.A. | -793 Thousand PLN | 223.96% |
| Medinice S.A. | 75 Thousand PLN | -1210.667% |
| Medicalgorithmics S.A. | 35.86 Million PLN | 97.259% |
| Synektik Spólka Akcyjna | 190.86 Million PLN | 99.485% |